JESSICA LUCENTE: Open Payments
NPI 1356441406 · SUN CITY, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$966 in 45 payments from 19 companies in 2025. Trend: 2023 $130 · 2024 $911 · 2025 $966
Food & beverage: $966
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $150 |
| Amgen Inc. | 11 | $139 |
| GlaxoSmithKline, LLC. | 5 | $108 |
| Aimmune Therapeutics, Inc. | 4 | $108 |
| Novo Nordisk Inc | 5 | $99 |
| Corcept Therapeutics | 3 | $73 |
| Abbott Laboratories | 2 | $38 |
| Dexcom, Inc. | 2 | $35 |
| Inspire Medical Systems, Inc. | 1 | $26 |
| SANOFI-AVENTIS U.S. LLC | 1 | $26 |
Products named: FARXIGA, OTEZLA, TRELEGY ELLIPTA, ZENPEP, Korlym, Ozempic, Dexcom G6 Transmitter, INSPIRE.
Industry payments across AZ — which companies pay providers there.
